Source: http://www.law.cornell.edu/uscode/text/21/1707?qt-us_code_tabs=1
Timestamp: 2014-08-02 05:10:44
Document Index: 577370012

Matched Legal Cases: ['§ 1707', '§ 708', '§ 401', '§ 401', '§ 401', '§ 401', '§ 401', '§ 401', '§ 401', '§ 401', '§ 401']

21 U.S. Code § 1707 - Counter-Drug Technology Assessment Center | LII / Legal Information Institute
Establishment There is established within the Office the Counter-Drug Technology Assessment Center (referred to in this section as the “Center”). The Center shall operate under the authority of the Director of National Drug Control Policy and shall serve as the central counter-drug technology research and development organization of the United States Government.
Chief Scientist There shall be at the head of the Center the Chief Scientist, who shall be appointed by the Director from among individuals qualified and distinguished in the area of science, medicine, engineering, or technology.
Research and development responsibilities The Director, acting through the Chief Scientist, shall—
identify and define the short-, medium-, and long-term scientific and technological needs of Federal, State, local, and tribal drug supply reduction agencies, including—
identify demand reduction basic and applied research needs and initiatives, in consultation with affected National Drug Control Program agencies, including—
provide support to the development and implementation of the national drug control performance measurement system established under subsection (c) ofsection 1705 of this title; and
Limitation on authority The authority granted to the Director under this section shall not extend to the awarding of contracts, management of individual projects, or other operational activities.
Assistance and support to the Office of National Drug Control Policy The Secretary of Defense, the Secretary of Homeland Security, and the Secretary of Health and Human Services shall, to the maximum extent practicable, render assistance and support to the Office and to the Director in the conduct of counterdrug technology assessment.
Technology transfer program (1)
Program The Chief Scientist, with the advice and counsel of experts from State, local, and tribal law enforcement agencies, shall be responsible to the Director for coordination and implementation of a counterdrug technology transfer program.
Purpose The purpose of the Technology Transfer Program shall be for the Counterdrug Technology Assessment Center to transfer technology and associated training directly to State, local, and tribal law enforcement agencies.
Priority of receipts Transfers shall be made in priority order based on—
Agreement authority The Director may enter into an agreement with the Secretary of Homeland Security to transfer technology with both counterdrug and homeland security applications to State, local, and tribal law enforcement agencies on a reimbursable basis.
Report On or before July 1 of each year, the Director shall submit a report to the appropriate congressional committees that addresses the following:
(Pub. L. 105–277, div. C, title VII, § 708,Oct. 21, 1998, 112 Stat. 2681–687; Pub. L. 109–469, title IV, § 401,Dec. 29, 2006, 120 Stat. 3525.)
2006—Subsec. (b). Pub. L. 109–469, § 401(a), amended subsec. (b) generally. Prior to amendment, text read as follows: “There shall be at the head of the Center the Director of Technology, who shall be appointed by the Director of National Drug Control Policy from among individuals qualified and distinguished in the area of science, medicine, engineering, or technology.”
Subsec. (c). Pub. L. 109–469, § 401(b)(1)(B), added subsec. (c) and struck out former subsec. (c) which related to additional responsibilities of the Director of National Drug Control Policy.
Subsec. (d). Pub. L. 109–469, § 401(c), which directed insertion of “, the Secretary of Homeland Security,” after “The Secretary of Defense”, could not be executed because the words “The Secretary of Defense” did not appear subsequent to amendment by Pub. L. 109–469, § 401(b)(1). See below.
Pub. L. 109–469, § 401(b)(1)(B), added subsec. (d). Former subsec. (d) redesignated (e).
Subsec. (e). Pub. L. 109–469, § 401(b)(2), amended subsec. (e) generally. Prior to amendment, text read as follows: “The Secretary of Defense and the Secretary of Health and Human Services shall, to the maximum extent practicable, render assistance and support to the Office and to the Director in the conduct of counter-drug technology assessment.”
Pub. L. 109–469, § 401(b)(1)(A), redesignatedsubsec. (d) as (e).
Subsec. (f). Pub. L. 109–469, § 401(b)(3), added subsec. (f).